Krystal Biotech
KRYS
#2547
Rank
NZ$9.62 B
Marketcap
$334.57
Share price
7.64%
Change (1 day)
99.84%
Change (1 year)

Revenue for Krystal Biotech (KRYS)

Revenue in 2024 (TTM): NZ$0.27 Billion

According to Krystal Biotech's latest financial reports the company's current revenue (TTM ) is NZ$0.27 Billion. In 2023 the company made a revenue of NZ$80.16 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Krystal Biotech from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.27 B239.44%
2023 NZ$80.16 M
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA